[DOI] [PubMed] [Google Scholar] 98.Shimizu H, Oh-I S, Okada S, Mori M
Neurotrophic support during healing phase
The following adverse effects were reported in patients receiving semaglutide injection or oral tablets across all clinical trials and at incidences higher than with placebo: nausea (11% to 44%), vomiting (5% to 24%), diarrhea (8.5% to 30%), abdominal pain (5.7% to 20%), abdominal distention (2% to 7%), constipation (3.1% to 24%), dyspepsia (0.6% to 9%), decreased appetite (6% to 9%), eructation (0.6% to 7%), flatulence (0.4% to 6%), gastroesophageal reflux disease (1.5% to 5%), gastroenteritis (4% to 6%), and gastritis (0.4% to 4%)
Regular check-ins during the menopausal transition help ensure that symptoms stay within expected ranges
CYANOKIT can cause kidney problems, including kidney failure
Peptides are strings of amino acids smaller than a protein that often act as signaling molecules in our bodies and carry out many critical functions
